ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Pfizer, GSK Join Vaccine Alliance

by Ann M. Thayer
March 29, 2010 | APPEARED IN VOLUME 88, ISSUE 13

GlaxoSmithKline and Pfizer are the first two companies to commit to providing vaccines against pneumococcal disease to the GAVI Alliance, a public-private health partnership. The two companies will each supply 30 million doses per year over 10 years. GAVI will make the vaccines available at low cost in developing countries, where the disease is a leading cause of death among young children. The supply agreements are part of an advance market commitment under which five governments and the Bill & Melinda Gates Foundation have agreed to fund $1.5 billion in vaccine purchases to provide incentives for vaccine developers and manufacturers.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment